References
1. Li X, Ostropolets A, Makadia R, et al. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.BMJ . 2021;373:n1435. doi:10.1136/bmj.n1435
2. COVID C, Team R. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 Vaccine—United States, December 21, 2020–January 10, 2021. Morbidity and Mortality Weekly Report . 2021;70(4):125.
3. Mohseni Afshar Z, Babazadeh A, Janbakhsh A, et al. Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients. Rev Med Virol . Jul 1 2021:e2273. doi:10.1002/rmv.2273
4. Ichikawa S, Kohata K, Okitsu Y, et al. Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy. Int J Hematol . Jul 2009;90(1):33-36. doi:10.1007/s12185-009-0347-9
5. Hafzah H, McGuire C, Hamad A. A Case of Acquired Hemophilia A Following SARS-CoV-2 Infection. Cureus . Jul 2021;13(7):e16579. doi:10.7759/cureus.16579
6. Radwi M, Farsi S. A case report of acquired hemophilia following COVID-19 vaccine. J Thromb Haemost . Jun 2021;19(6):1515-1518. doi:10.1111/jth.15291
7. Farley S, Ousley R, Van Wagoner N, Bril F. Autoimmunity after Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired Hemophilia A. Thromb Haemost . Aug 5 2021;doi:10.1055/a-1579-5396
8. Cittone MG, Battegay R, Condoluci A, et al. The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination. J Thromb Haemost . Sep 2021;19(9):2360-2362. doi:10.1111/jth.15421
9. Portuguese AJ, Sunga C, Kruse-Jarres R, Gernsheimer T, Abkowitz J. Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Adv . Jul 13 2021;5(13):2794-2798. doi:10.1182/bloodadvances.2021004957
10. Fueyo-Rodriguez O, Valente-Acosta B, Jimenez-Soto R, et al. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination. BMJ Case Rep . May 31 2021;14(5)doi:10.1136/bcr-2021-242220
11. Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).Vaccine . Jun 8 2021;39(25):3329-3332. doi:10.1016/j.vaccine.2021.04.054
12. Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol . May 1 2021;96(5):534-537. doi:10.1002/ajh.26132
13. Kim MA, Lee YW, Kim SR, et al. COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working Group. Allergy Asthma Immunol Res . Jul 2021;13(4):526-544. doi:10.4168/aair.2021.13.4.526
14. Tanno LK, Castells M, Caminati M, Senna G, Demoly P. Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship? Curr Opin Allergy Clin Immunol . Oct 1 2021;21(5):411-417. doi:10.1097/ACI.0000000000000778
15. Abi Zeid Daou C, Natout MA, El Hadi N. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.J Med Virol . Oct 2021;93(10):6027-6029. doi:10.1002/jmv.27109
16. Cabanillas B, Akdis CA, Novak N. COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: ”COVID-19 vaccine anaphylaxis: PEG or not?”. Allergy . Jun 2021;76(6):1938-1940. doi:10.1111/all.14725
17. Lee E, Lee YK, Kim TE, et al. Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021. Euro Surveill . Aug 2021;26(33)doi:10.2807/1560-7917.ES.2021.26.33.2100694
18. Bahloul M, Ketata W, Lahyeni D, et al. Pulmonary capillary leak syndrome following COVID-19 virus infection. J Med Virol . Jan 2021;93(1):94-96. doi:10.1002/jmv.26152
19. Wu MA, Fossali T, Pandolfi L, et al. Hypoalbuminemia in COVID-19: assessing the hypothesis for underlying pulmonary capillary leakage.J Intern Med . Jun 2021;289(6):861-872. doi:10.1111/joim.13208
20. Case R, Ramaniuk A, Martin P, Simpson PJ, Harden C, Ataya A. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.Chest . Dec 2020;158(6):e267-e268. doi:10.1016/j.chest.2020.06.049
21. Matheny M, Maleque N, Channell N, et al. Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series. Ann Intern Med . Jun 15 2021;doi:10.7326/L21-0250
22. Choi GJ, Baek SH, Kim J, et al. Fatal Systemic Capillary Leak Syndrome after SARS-COV-2Vaccination in Patient with Multiple Myeloma.Emerg Infect Dis . Aug 30 2021;27(11)doi:10.3201/eid2711.211723
23. Silva TF, Tomiotto-Pellissier F, Sanfelice RA, et al. A 21st Century Evil: Immunopathology and New Therapies of COVID-19. Front Immunol . 2020;11:562264. doi:10.3389/fimmu.2020.562264
24. Obeid M, Fenwick C, Pantaleo G. Reactivation of IgA vasculitis after COVID-19 vaccination. Lancet Rheumatol . Sep 2021;3(9):e617. doi:10.1016/S2665-9913(21)00211-3
25. Negrea L, Rovin BH. Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy. Kidney Int . Jun 2021;99(6):1487. doi:10.1016/j.kint.2021.03.002
26. Rahim SEG, Lin JT, Wang JC. A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination. Kidney Int . Jul 2021;100(1):238. doi:10.1016/j.kint.2021.04.024
27. Sirufo MM, Raggiunti M, Magnanimi LM, Ginaldi L, De Martinis M. Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report. Vaccines . 2021;9(10):1078.
28. Obeid M, Fenwick C, Pantaleo G. Reactivation of IgA vasculitis after COVID-19 vaccination. The Lancet Rheumatology . 2021;3(9):e617.
29. Cohen SR, Prussick L, Kahn JS, Gao DX, Radfar A, Rosmarin D. Leukocytoclastic vasculitis flare following the COVID-19 vaccine.Int J Dermatol . Aug 2021;60(8):1032-1033. doi:10.1111/ijd.15623
30. Bostan E, Gulseren D, Gokoz O. New-onset leukocytoclastic vasculitis after COVID-19 vaccine. Int J Dermatol . Oct 2021;60(10):1305-1306. doi:10.1111/ijd.15777
31. singh Arora K, Ariff M, Malik R, Kasar A, Patel C. COVID-19 Pfizer Vaccine associated case of Leukocytoclastic vasculitis. Cureus Journal of Medical Science . 2021;
32. Dash S, Behera B, Sethy M, Mishra J, Garg S. COVID-19 vaccine-induced urticarial vasculitis. Dermatol Ther . Aug 8 2021:e15093. doi:10.1111/dth.15093
33. Frumholtz L, Laurent-Roussel S, Lipsker D, Terrier B. Cutaneous Vasculitis: Review on Diagnosis and Clinicopathologic Correlations.Clin Rev Allergy Immunol . Oct 2021;61(2):181-193. doi:10.1007/s12016-020-08788-4
34. Vassallo C, Boveri E, Brazzelli V, et al. Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine. Dermatol Ther . Jul 30 2021:e15076. doi:10.1111/dth.15076
35. Terracina KA, Tan FK. Flare of rheumatoid arthritis after COVID-19 vaccination. The Lancet Rheumatology . 2021;
36. Ray P, Black S, Shinefield H, et al. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15–59 years of age. Vaccine . 2011;29(38):6592-6597.
37. Bixio R, Bertelle D, Masia M, Pistillo F, Carletto A, Rossini M. Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission.ACR Open Rheumatol . Sep 2 2021;doi:10.1002/acr2.11336
38. An QJ, Qin DA, Pei JX. Reactive arthritis after COVID-19 vaccination. Hum Vaccin Immunother . Sep 2 2021;17(9):2954-2956. doi:10.1080/21645515.2021.1920274
39. Horino T. IgA nephropathy flare-up following SARS-CoV-2 vaccination.QJM . Aug 20 2021;doi:10.1093/qjmed/hcab223
40. Hanna C, Hernandez LPH, Bu L, et al. IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine. Kidney international . 2021;100(3):705-706.
41. Abramson M, Mon-Wei Yu S, Campbell KN, Chung M, Salem F. IgA Nephropathy After SARS-CoV-2 Vaccination. Kidney Med . Sep-Oct 2021;3(5):860-863. doi:10.1016/j.xkme.2021.05.002
42. Plasse R, Nee R, Gao S, Olson S. Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination. Kidney Int . Oct 2021;100(4):944-945. doi:10.1016/j.kint.2021.07.020
43. Oyibo SO. Subacute Thyroiditis After Receiving the Adenovirus-Vectored Vaccine for Coronavirus Disease (COVID-19).Cureus . Jun 2021;13(6):e16045. doi:10.7759/cureus.16045
44. Ratnayake GM, Dworakowska D, Grossman AB. Can COVID‐19 immunisation cause subacute thyroiditis? Clinical Endocrinology . 2021;
45. Franquemont S, Galvez J. Subacute Thyroiditis After mRNA Vaccine for Covid-19. Journal of the Endocrine Society . 2021;5(Suppl 1):A956.
46. Norouzi G. Subacute Thyroiditis Following COVID-19 Vaccination.Authorea Preprints . 2021;
47. İremli BG, Şendur SN, Ünlütürk U. Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Post-vaccination ASIA Syndrome. The Journal of Clinical Endocrinology & Metabolism . 2021;
48. Stasiak M, Lewinski A. New aspects in the pathogenesis and management of subacute thyroiditis. Rev Endocr Metab Disord . May 5 2021:1-13. doi:10.1007/s11154-021-09648-y
49. Sahin Tekin M, Saylisoy S, Yorulmaz G. Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report. Hum Vaccin Immunother . Jul 1 2021:1-3. doi:10.1080/21645515.2021.1947102
50. Girgis CM, Russo RR, Benson K. Subacute thyroiditis following the H1N1 vaccine. J Endocrinol Invest . Jul-Aug 2010;33(7):506. doi:10.1007/BF03346633
51. Altay FA, Guz G, Altay M. Subacute thyroiditis following seasonal influenza vaccination. Hum Vaccin Immunother . Apr 2 2016;12(4):1033-4. doi:10.1080/21645515.2015.1117716
52. Toft J, Larsen S, Toft H. Subacute thyroiditis after hepatitis B vaccination. Endocr J . Feb 1998;45(1):135.
53. Hsiao JY, Hsin SC, Hsieh MC, Hsia PJ, Shin SJ. Subacute thyroiditis following influenza vaccine (Vaxigrip®) in a young female. The Kaohsiung journal of medical sciences . 2006;22(6):297-300.
54. Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y. ASIA syndrome and endocrine autoimmune disorders. Best Pract Res Clin Endocrinol Metab . Jan 2020;34(1):101412. doi:10.1016/j.beem.2020.101412
55. Bornemann C, Woyk K, Bouter C. Case Report: Two Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccination. Front Med (Lausanne) . 2021;8:737142. doi:10.3389/fmed.2021.737142
56. Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, Sanchez Valadez TI, Jara LJ. Two Cases of Graves’ Disease Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by Adjuvants. Thyroid . Sep 2021;31(9):1436-1439. doi:10.1089/thy.2021.0142
57. Goa KL, Benfield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs . Mar 1994;47(3):536-66. doi:10.2165/00003495-199447030-00009
58. Ghasemi S, Dashti M. Fight against COVID-19 with mRNA vaccines and interaction with Dermal fillers. Clin Exp Vaccine Res . May 2021;10(2):151-153. doi:10.7774/cevr.2021.10.2.151
59. Michon A. Hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination - A case report. J Cosmet Dermatol . Sep 2021;20(9):2684-2690. doi:10.1111/jocd.14312
60. Nlandu YM, Makulo JR, Pakasa NM, et al. First Case of COVID-19-Associated Collapsing Glomerulopathy in Sub-Saharan Africa.Case Rep Nephrol . 2020;2020:8820713. doi:10.1155/2020/8820713
61. Raza A, Estepa A, Chan V, Jafar MS. Acute Renal Failure in Critically Ill COVID-19 Patients With a Focus on the Role of Renal Replacement Therapy: A Review of What We Know So Far. Cureus . Jun 3 2020;12(6):e8429. doi:10.7759/cureus.8429
62. Lebedev L, Sapojnikov M, Wechsler A, et al. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. Am J Kidney Dis . Jul 2021;78(1):142-145. doi:10.1053/j.ajkd.2021.03.010
63. Lim JH, Han MH, Kim YJ, et al. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review.J Korean Med Sci . Aug 2 2021;36(30):e218. doi:10.3346/jkms.2021.36.e218
64. Leclerc S, Royal V, Lamarche C, Laurin LP. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report. Am J Kidney Dis . Oct 2021;78(4):607-610. doi:10.1053/j.ajkd.2021.06.008
65. Sanchez Tinajero A, Gonzalez Cueto E, Martinez Orozco JA, Becerril Vargas E, Ruiz Santillan DP, Resendiz Escobar H. A 65-Year-Old Woman with a History of Type 2 Diabetes Mellitus and Hypertension and a 15-Day History of Dry Cough and Fever Who Presented with Acute Renal Failure Due to Infection with SARS-Cov-2. Am J Case Rep . Jul 25 2020;21:e926737. doi:10.12659/AJCR.926737
66. Eder M, Strassl R, Klager J, Aigner C, Thalhammer F, Kikic Z. COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease. Wien Klin Wochenschr . Apr 2021;133(7-8):412-413. doi:10.1007/s00508-020-01776-w
67. Su JR, Haber P, Ng CS, et al. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017. Vaccine . Feb 11 2020;38(7):1746-1752. doi:10.1016/j.vaccine.2019.12.028
68. Rongioletti F, Ferreli C, Sena P, Caputo V, Atzori L. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns.Clin Dermatol . Jan-Feb 2021;39(1):149-162. doi:10.1016/j.clindermatol.2020.12.004
69. Bonino CB, Arias NM, Rico ML-P, et al. Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine.International journal of dermatology . 2021;doi:https://doi.org/10.1111/ijd.15894
70. Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment.Dent Clin North Am . Oct 2013;57(4):583-96. doi:10.1016/j.cden.2013.07.001
71. Clinic M. Chilblains. Mayo Clinic.
72. Ayatollahi A, Hosseini H, Firooz R, Firooz A. COVID-19 vaccines: What dermatologists should know? Dermatol Ther . Jul 7 2021;n/a(n/a):e15056. doi:10.1111/dth.15056
73. Pileri A, Guglielmo A, Raone B, Patrizi A. Chilblain lesions after COVID-19 mRNA vaccine. Br J Dermatol . Jul 2021;185(1):e3. doi:10.1111/bjd.20060
74. Temiz SA, Abdelmaksoud A, Dursun R, Vestita M. Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination. Int J Dermatol . Sep 2021;60(9):1152-1153. doi:10.1111/ijd.15619
75. Davido B, Mascitti H, Fortier-Beaulieu M, Jaffal K, de Truchis P. ‘Blue toes’ following vaccination with the BNT162b2 mRNA COVID-19 vaccine. Journal of Travel Medicine . 2021;28(4):taab024.
76. Piccolo V, Bassi A, Argenziano G, et al. BNT162b2 mRNA COVID‐19 vaccine‐induced chilblain‐like lesions reinforces the hypothesis of their relationship with SARS‐CoV‐2. Journal of the European Academy of Dermatology and Venereology . 2021;
77. D’Agostino V, Caranci F, Negro A, et al. A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration. J Pers Med . Apr 8 2021;11(4)doi:10.3390/jpm11040285
78. Turetz M, Sideris AT, Friedman OA, Triphathi N, Horowitz JM. Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism. Semin Intervent Radiol . Jun 2018;35(2):92-98. doi:10.1055/s-0038-1642036
79. Kesieme E, Kesieme C, Jebbin N, Irekpita E, Dongo A. Deep vein thrombosis: a clinical review. J Blood Med . 2011;2:59-69. doi:10.2147/JBM.S19009
80. Greinacher A, Langer F, Makris M, et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources. J Thromb Haemost . Jan 2022;20(1):149-156. doi:10.1111/jth.15572
81. Shakibajahromi B, Borhani-Haghighi A, Haseli S, Mowla A. Cerebral venous sinus thrombosis might be under-diagnosed in the COVID-19 era.Eneurologicalsci . 2020;20
82. Shakibajahromi B, Borhani-Haghighi A, Ghaedian M, et al. Early, delayed, and expanded intracranial hemorrhage in cerebral venous thrombosis. Acta Neurol Scand . Dec 2019;140(6):435-442. doi:10.1111/ane.13164
83. Shakibajahromi B, Haghighi AB, Salehi A, et al. Clinical and radiological characteristics and predictors of outcome of cerebral venous sinus thrombosis, a hospital-based study. Acta Neurol Belg . Aug 2020;120(4):845-852. doi:10.1007/s13760-018-1009-6
84. Mowla A, Shakibajahromi B, Shahjouei S, et al. Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series.J Neurol Sci . Dec 15 2020;419:117183. doi:10.1016/j.jns.2020.117183
85. Furie KL, Cushman M, Elkind MSV, Lyden PD, Saposnik G, American Heart Association/American Stroke Association Stroke Council L. Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia. Stroke . Jul 2021;52(7):2478-2482. doi:10.1161/STROKEAHA.121.035564
86. Ostovan VR, Foroughi R, Rostami M, et al. Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review. J Neurol . Oct 2021;268(10):3549-3560. doi:10.1007/s00415-021-10450-8
87. Vayne C, Nguyen T-H, Rollin J, et al. Characterization of new monoclonal PF4-specific antibodies as useful tools for studies on typical and autoimmune heparin-induced thrombocytopenia.Thrombosis and Haemostasis . 2021;121(03):322-331.
88. Cines DB, Bussel JB. SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia [published correction appears in N Engl J Med. 2021 Jun 10;384(23):e92]. N Engl J Med . 2021;384(23):2254-2256. doi:10.1056/NEJMe2106315
89. Mehta PR, Apap Mangion S, Benger M, et al. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination - A report of two UK cases. Brain Behav Immun . Jul 2021;95:514-517. doi:10.1016/j.bbi.2021.04.006
90. Hernández AF, Calina D, Poulas K, Docea AO, Tsatsakis AM. Safety of COVID-19 vaccines administered in the EU: Should we be concerned?Toxicology Reports . 2021;8:871-879.
91. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.N Engl J Med . Jun 3 2021;384(22):2092-2101. doi:10.1056/NEJMoa2104840
92. McCrae KR. Thrombotic thrombocytopenia due to SARS-CoV-2 vaccination. Cleveland Clinic Journal of Medicine . 2021;
93. Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, Mohammadi P, Nomovi M, Mowla A. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J Neurol Sci . Sep 15 2021;428:117607. doi:10.1016/j.jns.2021.117607
94. Scully M, Singh D, Lown R, et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med . Jun 10 2021;384(23):2202-2211. doi:10.1056/NEJMoa2105385
95. Committee PRA. COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets . 2021.
96. Oldenburg J, Klamroth R, Langer F, et al. Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH. Hämostaseologie . 2021;
97. Valeriani E, Riva N, Di Nisio M, Ageno W. Splanchnic Vein Thrombosis: Current Perspectives. Vasc Health Risk Manag . 2019;15:449-461. doi:10.2147/VHRM.S197732
98. Aalberg JJ, Collins TP, Dobrow EM. Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 Vaccination. Radiol Case Rep . Aug 2021;16(8):2164-2167. doi:10.1016/j.radcr.2021.05.031
99. Faermann R, Nissan N, Halshtok-Neiman O, et al. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases. Acad Radiol . Sep 2021;28(9):1191-1197. doi:10.1016/j.acra.2021.06.003
100. Mehta N, Sales RM, Babagbemi K, et al. Unilateral axillary Adenopathy in the setting of COVID-19 vaccine. Clinical imaging . 2021;75:12-15.
101. Eifer M, Eshet Y. Imaging of COVID-19 Vaccination at FDG PET/CT.Radiology . 2021;299(2):E248-E248.
102. Özütemiz C, Krystosek LA, Church AL, et al. Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncology patients.Radiology . 2021:210275.
103. Keshavarz P, Yazdanpanah F, Rafiee F, Mizandari M. Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review. Acad Radiol . Aug 2021;28(8):1058-1071. doi:10.1016/j.acra.2021.04.007
104. Pereira MP, Flores P, Neto AS. Neck and supraclavicular lymphadenopathy secondary to 9-valent human papillomavirus vaccination.BMJ Case Rep . Nov 5 2019;12(11):e231582. doi:10.1136/bcr-2019-231582
105. Barouni AS, Augusto C, Queiroz MV, Lopes MT, Zanini MS, Salas CE. BCG lymphadenopathy detected in a BCG-vaccinated infant. Braz J Med Biol Res . May 2004;37(5):697-700. doi:10.1590/s0100-879x2004000500011
106. Katzir Z, Okon E, Ludmirski A, Sherman Y, Haas H. Generalized lymphadenitis following BCG vaccination in an immunocompetent 12-year-old boy. European journal of pediatrics . 1984;141(3):165-167.
107. Shlamovitz GZ, Johar S. A case of Evans’ syndrome following influenza vaccine. J Emerg Med . Feb 2013;44(2):e149-51. doi:10.1016/j.jemermed.2012.01.060
108. Toy H, Karasoy D, Keser M. Lymphadenitis caused by H1N1 vaccination: case report. Vaccine . Mar 2 2010;28(10):2158-2160. doi:10.1016/j.vaccine.2009.12.043
109. Sever JL, Brenner AI, Gale AD, et al. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiol Drug Saf . Dec 2004;13(12):825-40. doi:10.1002/pds.936
110. Hiller N, Goldberg SN, Cohen-Cymberknoh M, Vainstein V, Simanovsky N. Lymphadenopathy Associated With the COVID-19 Vaccine. Cureus . Feb 23 2021;13(2):e13524. doi:10.7759/cureus.13524
111. Abou-Foul AK, Ross E, Abou-Foul M, George AP. Cervical lymphadenopathy following COVID-19 vaccine: Clinical characteristics and implications for head and neck cancer services. Authorea Preprints . 2021;
112. Singh B, Kaur P, Kumar V, Maroules M. COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan. Radiol Case Rep . Jul 2021;16(7):1819-1821. doi:10.1016/j.radcr.2021.04.053
113. Fernández-Prada M, Rivero-Calle I, Calvache-González A, Martinón-Torres F. Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021. Eurosurveillance . 2021;26(10):2100193.
114. Tandon S, Shahab R, Benton JI, Ghosh SK, Sheard J, Jones TM. Fine-needle aspiration cytology in a regional head and neck cancer center: comparison with a systematic review and meta-analysis.Head Neck . Sep 2008;30(9):1246-52. doi:10.1002/hed.20849
115. Edmonds CE, Zuckerman SP, Conant EF. Management of unilateral axillary lymphadenopathy detected on breast MRI in the era of coronavirus disease (COVID-19) vaccination. American Journal of Roentgenology . 2021;
116. Seely JM, Barry MH. The Canadian Society of Breast Imaging Recommendations for the Management of Axillary Adenopathy in Patients with Recent COVID-19 Vaccination - Update. Canadian Association of Radiologists Journal . 2021;72(4):601-602. doi:10.1177/0846537121998949
117. Lehman CD, D’Alessandro HA, Mendoza DP, Succi MD, Kambadakone A, Lamb LR. Unilateral Lymphadenopathy After COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties. J Am Coll Radiol . Jun 2021;18(6):843-852. doi:10.1016/j.jacr.2021.03.001
118. Hagen C, Nowack M, Messerli M, Saro F, Mangold F, Bode PK. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.Swiss Med Wkly . Jul 19 2021;151:w20557. doi:10.4414/smw.2021.20557
119. Al Soub H, Ibrahim W, Al Maslamani M, Abbas G, Ummer W. Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report.IDCases . 2021:e01253.
120. Kucukardali Y, Solmazgul E, Kunter E, Oncul O, Yildirim S, Kaplan M. Kikuchi-Fujimoto Disease: analysis of 244 cases. Clin Rheumatol . Jan 2007;26(1):50-4. doi:10.1007/s10067-006-0230-5
121. Watanabe T, Hashidate H, Hirayama Y, Iinuma Y. Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis. Eur J Pediatr . Sep 2012;171(9):1409-11. doi:10.1007/s00431-012-1729-1
122. Podugu A, Kobe M. Kikuchi-Fujimoto Disease (KFD): A Rare Cause of Fever and Lymphadenopathy Following Influenza Vaccination. Chest . 2013;144(4):230A.
123. Maleki A, Look-Why S, Manhapra A, Foster CS. COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence? J Ophthalmic Vis Res . Jul-Sep 2021;16(3):490-501. doi:10.18502/jovr.v16i3.9443
124. Turbeville SD, Cowan LD, Gass JD. Acute macular neuroretinopathy: a review of the literature. Surv Ophthalmol . Jan-Feb 2003;48(1):1-11. doi:10.1016/s0039-6257(02)00398-3
125. Book BAJ, Schmidt B, Foerster AMH. Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2. JAMA Ophthalmol . Jul 1 2021;139(7):e212471. doi:10.1001/jamaophthalmol.2021.2471
126. Bohler AD, Strom ME, Sandvig KU, Moe MC, Jorstad OK. Acute macular neuroretinopathy following COVID-19 vaccination. Eye (Lond) . Jun 22 2021:1-2. doi:10.1038/s41433-021-01610-1
127. Scharf J, Freund KB, Sadda S, Sarraf D. Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses.Prog Retin Eye Res . Mar 2021;81:100884. doi:10.1016/j.preteyeres.2020.100884
128. Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG. Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi. JAMA Ophthalmol . Sep 2 2021;doi:10.1001/jamaophthalmol.2021.3477
129. Semeraro F, Morescalchi F, Russo A, et al. Central Serous Chorioretinopathy: Pathogenesis and Management. Clin Ophthalmol . 2019;13:2341-2352. doi:10.2147/OPTH.S220845
130. Fowler N, Mendez Martinez NR, Pallares BV, Maldonado RS. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep . Sep 2021;23:101136. doi:10.1016/j.ajoc.2021.101136
131. Subramony R, Lin LC, Knight DK, Aminlari A, Belovarski I. Bilateral Retinal Detachments in a Healthy 22-year-old Female Following Moderna SARS-CoV-2 Vaccination. The Journal of Emergency Medicine . 2021;
132. Renisi G, Lombardi A, Stanzione M, Invernizzi A, Bandera A, Gori A. Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? International Journal of Infectious Diseases . 2021;110:95-97.
133. Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following Vaccination for COVID-19. Ocul Immunol Inflamm . May 19 2021;29(4):741-742. doi:10.1080/09273948.2021.1949478
134. Goyal M, Murthy SI, Annum S. Bilateral Multifocal Choroiditis following COVID-19 Vaccination. Ocul Immunol Inflamm . May 19 2021;29(4):753-757. doi:10.1080/09273948.2021.1957123
135. Saraceno JJF, Souza GM, Dos Santos Finamor LP, Nascimento HM, Belfort R, Jr. Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. Int J Retina Vitreous . Aug 30 2021;7(1):49. doi:10.1186/s40942-021-00319-3
136. Hong J, Chopra S, Kahn J, Kim B, Khemichian S. Autoimmune hepatitis triggered by COVID-19. Intern Med J . 2021;51(7):1182-1183. doi:10.1111/imj.15420
137. McShane C, Kiat C, Rigby J, Crosbie O. The mRNA COVID-19 vaccine - A rare trigger of autoimmune hepatitis? J Hepatol . Jul 8 2021;doi:10.1016/j.jhep.2021.06.044
138. Rela M, Jothimani D, Vij M, Rajakumar A, Rammohan A. Auto-immune hepatitis following COVID vaccination. J Autoimmun . Sep 2021;123:102688. doi:10.1016/j.jaut.2021.102688
139. Lu L, Liu M, Sun R, Zheng Y, Zhang P. Myocardial Infarction: Symptoms and Treatments. Cell Biochem Biophys . Jul 2015;72(3):865-7. doi:10.1007/s12013-015-0553-4
140. Chatterjee S, Ojha UK, Vardhan B, Tiwari A. Myocardial infarction after COVID-19 vaccination-casual or causal? Diabetes Metab Syndr . May-Jun 2021;15(3):1055-1056. doi:10.1016/j.dsx.2021.04.006
141. Boivin Z, Martin J. Untimely Myocardial Infarction or COVID-19 Vaccine Side Effect. Cureus . Mar 2 2021;13(3):e13651. doi:10.7759/cureus.13651
142. Maadarani O, Bitar Z, Elzoueiry M, et al. Myocardial infarction post COVID-19 vaccine–coincidence, Kounis syndrome or other explanation–time will tell. JRSM open . 2021;12(8):20542704211025259.
143. Oakley CM. Myocarditis, pericarditis and other pericardial diseases. Heart . Oct 2000;84(4):449-54. doi:10.1136/heart.84.4.449
144. Singer ME, Taub IB, Kaelber DC. Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis.medRxiv . Jul 27 2021;doi:10.1101/2021.07.23.21260998
145. Luk A, Clarke B, Dahdah N, et al. Myocarditis and Pericarditis following COVID-19 mRNA Vaccination: Practical Considerations for Care Providers. Canadian Journal of Cardiology . 2021;
146. Das BB, Moskowitz WB, Taylor MB, Palmer A. Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far? Children . 2021;8(7):607.
147. Ramirez-Garcia A, Lozano Jimenez S, Darnaude Ximenez I, Gil Cacho A, Aguado-Noya R, Segovia Cubero J. Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Rev Esp Cardiol (Engl Ed) . Jul 16 2021;doi:10.1016/j.rec.2021.07.005
148. Diaz GA, Parsons GT, Gering SK, Meier AR, Hutchinson IV, Robicsek A. Myocarditis and Pericarditis After Vaccination for COVID-19.JAMA . Sep 28 2021;326(12):1210-1212. doi:10.1001/jama.2021.13443
149. Prasad A, Hurlburt G, Podury S, Tandon M, Kingree S, Sriwastava S. A Novel Case of Bifacial Diplegia Variant of Guillain-Barre Syndrome Following Janssen COVID-19 Vaccination. Neurol Int . Aug 13 2021;13(3):404-409. doi:10.3390/neurolint13030040
150. Hasan T, Khan M, Khan F, Hamza G. Case of Guillain-Barre syndrome following COVID-19 vaccine. BMJ Case Rep . Jun 29 2021;14(6):e243629. doi:10.1136/bcr-2021-243629
151. Trimboli M, Zoleo P, Arabia G, Gambardella A. Guillain-Barre syndrome following BNT162b2 COVID-19 vaccine. Neurol Sci . Aug 4 2021:1-2. doi:10.1007/s10072-021-05523-5
152. Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus . 2021;13(2)
153. Introna A, Caputo F, Santoro C, et al. Guillain-Barre syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?Clin Neurol Neurosurg . Sep 2021;208:106887. doi:10.1016/j.clineuro.2021.106887
154. Scendoni R, Petrelli C, Scaloni G, Logullo FO. Electromyoneurography and laboratory findings in a case of Guillain-Barre syndrome after second dose of Pfizer COVID-19 vaccine.Hum Vaccin Immunother . Aug 4 2021:1-4. doi:10.1080/21645515.2021.1954826
155. McKean N, Chircop C. Guillain-Barre syndrome after COVID-19 vaccination. BMJ Case Rep . Jul 30 2021;14(7):e244125. doi:10.1136/bcr-2021-244125
156. ChC E, Zeller J, Stingele R. Stroke: causes and classification.Hamostaseologie . 2006;26(4):298-308.
157. Markus HS. Ischaemic stroke can follow COVID-19 vaccination but is much more common with COVID-19 infection itself. Journal of Neurology, Neurosurgery & Psychiatry . 2021;doi:10.1136/jnnp-2021-327057
158. Blauenfeldt RA, Kristensen SR, Ernstsen SL, Kristensen CCH, Simonsen CZ, Hvas AM. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J Thromb Haemost . Jul 2021;19(7):1771-1775. doi:10.1111/jth.15347
159. Mason MC, Liaqat A, Morrow J, Basso R, Gujrati Y. Bilateral Facial Nerve Palsy and COVID-19 Vaccination: Causation or Coincidence?Cureus . Aug 2021;13(8):e17602. doi:10.7759/cureus.17602
160. Burrows A, Bartholomew T, Rudd J, Walker D. Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Rep . Jul 19 2021;14(7):e243829. doi:10.1136/bcr-2021-243829
161. Gupta S, Jawanda MK, Taneja N, Taneja T. A systematic review of Bell’s Palsy as the only major neurological manifestation in COVID-19 patients. Journal of Clinical Neuroscience . 2021;90:284-292.
162. Sato K, Mano T, Niimi Y, Toda T, Iwata A, Iwatsubo T. Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. Int J Infect Dis . Sep 4 2021;111:310-312. doi:10.1016/j.ijid.2021.08.071
163. Soeiro T, Salvo F, Pariente A, Grandvuillemin A, Jonville-Béra A-P, Micallef J. Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell’s palsy. Therapie . 2021;
164. Tahir N, Koorapati G, Prasad S, et al. SARS-CoV-2 Vaccination-Induced Transverse Myelitis. Cureus . 2021;13(7)
165. Roman GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol . 2021;12:653786. doi:10.3389/fimmu.2021.653786
166. Khan E, Shrestha AK, Colantonio MA, Liberio RN, Sriwastava S. Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. Journal of Neurology . 2021:1-12.
167. Group TMCW. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002; 59: 499–505. QJM: An International Journal of Medicine . 2020;
168. Pagenkopf C, Sudmeyer M. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol . Sep 15 2021;358:577606. doi:10.1016/j.jneuroim.2021.577606
169. Notghi AA, Atley J, Silva M. Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clin Med (Lond) . Sep 2021;21(5):e535-e538. doi:10.7861/clinmed.2021-0470